Increased mast cell infiltration in familial varicose veins: Pathogenetic implications?

International Angiology

Volumn 22, Issue 1, 2003, Pages 43-49

  Kakkos, S K ^a,b   Zolota, V G ^a   Peristeropoulou, P ^a   Apostolopoulou, A ^a   Geroukalos, G ^b   Tsolakis, I A ^a  

^a UNIVERSITY OF PATRAS   (Greece)

^b ST MARY S HOSPITAL   (United Kingdom)

Author keywords

Mast cells; Varicose vein, pathophysiology; Varicose veins, hereditary

Indexed keywords

ADULT; AGE; ARTICLE; BLOOD VESSEL WALL; BODY MASS; CELL ACTIVITY; CELL COUNT; CELL INFILTRATION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE DURATION; FAMILY HISTORY; FEMALE; GENDER; HUMAN; HUMAN TISSUE; HYPERTENSION; LEG VARICOSIS; MALE; MAST CELL; PATHOGENESIS; PATHOPHYSIOLOGY; PHYSICAL EXAMINATION; PREGNANCY COMPLICATION; SAPHENOUS VEIN; SYMPTOMATOLOGY; TISSUE SECTION; VASCULAR SURGERY;

ADULT; CELL COUNT; FEMALE; HUMANS; MALE; MAST CELLS; SAPHENOUS VEIN; VARICOSE VEINS;

EID: 0038048008     PISSN: 03929590     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Corcos L, Procacci T, Peruzzi G, Dini M, De Anna D. Sapheno-femoral valves. Histopathological observations and diagnostic approach before surgery. Dermatol Surg 1996;22:873-80.
2. Zelikovski A, Zamir B, Hadar H, Urca I. Sapheno-femoral valve insufficiency in varicose veins of the lower limb. Angiology 1981;32:807-11.
3. Clarke GH, Vasdekis SN, Hobbs JT, Nicolaides AN. Venous wall function in the pathogenesis of varicose veins. Surgery 1992;111:402-8.
4. Baron HC, Cassaro S. The role of arteriovenous shunts in the pathogenesis of varicose veins. J Vasc Surg 1986;4:124-8.
5. Crotty TP. The role of radial reflux in the genesis of varicose veins. Med Hypotheses 1996;47:449-54.
6. Arnoldi CC. The heredity of venous insufficiency. Dan Med Bull 1958;5:169-76.
7. Yamada T, Tomita S, Mori M, Sasatomi E, Suenaga E, Itoh T. Increased mast cell infiltration in varicose veins of the lower limbs: a possible role in the development of varices. Surgery 1996;119:494-7.
8. Yamada T, Yamamoto H, Ogawa A, Miyazaki K, Tokunaga O, Itoh T. Ultrastructural demonstration of mast cells in varicose veins of lower limbs: presence of mast cell-mediated mechanism. J Cardiovasc Surg 1997;38:443-6.
9. Porter JM, Moneta GL and an international consensus committee on chronic venous disease. Reporting standards in venous disease: an update. J Vasc Surg 1995;21:635-45.
10. Kistner RL, Eklof B, Masuda EM. Diagnosis of chronic venous disease of the lower extremities: the "CEAP" classification. Mayo Clin Proc 1996;71:338-45.
11. Venturi M, Bonavina L, Annoni F, Colombo L, Butera C, Peracchia A et al. Biochemical assay of collagen and elastin in the normal and varicose vein wall. J Surg Res 1996;60:245-8.
12. Cornu-Thenard A, Boivin P, Baud J-M, Vincenzi P, Carpentier PH. Importance of the familiar factor in varicose disease. Clinical study of 134 families. J Dermatol Surg Oncol 1994;20:318-26.
13. Stvrtinova V, Kolesar J, Wimmer G. Prevalence of varicose veins of the lower limbs in the women working at a department store. Int Angiol 1991;10:2-5.
14. Sadick NS. Predisposing factors of varicose and telangiectatic leg veins. J Dermatol Surg Oncol 1992;18: 883-6.
15. Scappaticci S, Capra E, Cortinovis M, Cortinovis R, Arbustini E, Diegoli M et al. Cytogenetic studies in venous tissue from patients with varicose veins. Cancer Genet Cytogenet 1994;75:26-30.
16. Kockx MM, Knaapen MW, Bortier HE, Cromheeke KM, Boutherin-Falson O, Finet M. Vascular remodeling in varicose veins. Angiology 1998;49:871-7.
17. Rose SS, Ahmed A. Some thoughts on the aetiology of varicose veins. J Cardiovasc Surg 1986;27:534-43.
18. Meier HL, Schulman ES, Heck LW, MacGlashan D, Newball HH, Kaplan AP. Release of elastase from purified human lung mast cells and basophils. Identification as a Hageman factor cleaving enzyme. Inflammation 1989;13: 295-308.
19. He S, Walls AF. Human mast cell tryptase: a stimulus of microvascular leakage and mast cell activation. Eur J Pharmacol 1997;328:89-97.
20. Kanbe N, Tanaka A, Kanbe M, Itakura A, Kurosawa M, Matsuda H. Human mast cells produce matrix metalloproteinase 9. Eur J Immunol 1999;29:2645-9.
21. Borish L, Joseph BZ. Inflammation and the allergic response. Med Clin North Am 1992;76:765-87.
22. Ulloa J Jr, Quist WC, Phaneuf MD, Brewster DC, LoGerfo FW, Villavicencio JL. High levels of mast cell tryptase in primary varicose veins: an etiological factor? Int Angiol 2000; 19(1 Suppl 2):80.
23. Lees M, Taylor DJ, Woolley DE. Mast cell proteinases activate precursor forms of collagenase and stromelysin, but not of gelatinases A and B. Eur J Biochem 1994;223:171-7.
24. Johnson JL, Jackson CL, Angelini GD, George SJ. Activation of matrix-degrading metalloproteinases by mast cell proteases in atherosclerotic plaques. Arterioscler Thromb Vasc Biol 1998;18:1707-15.
25. El-Ackad TM, Brody MJ. Evidence for non-mast cell histamine in the vascular wall. Blood Vessels 1975;12: 181-91.
26. Bigel P, Taccoen A. Morphology and vascularization of the varicose internal saphenous vein. Comparison with the normal structure. J Mal Vasc 1996;21 Suppl C: 249-52.
27. Mierke CT, Ballmaier M, Werner U, Manns MP, Welte K, Bischoff SC. Human endothelial cells regulate survival and proliferation of human mast cells. J Exp Med 2000;192:801-11.
28. Blair RJ, Meng H, Marchese MJ, Ren S, Schwartz LB, Tonnesen MG et al. Human mast cells stimulate vascular tube formation. Tryptase is a novel, potent angiogenic factor. J Clin Invest 1997;99:2691-700.
29. Takase S, Bergan JJ, Schmid-Schonbein G. Expression of adhesion molecules and cytokines on saphenous veins in chronic venous insufficiency. Ann Vasc Surg 2000;14:427-35.
30. Gilbert RE, Rumble JR, Cao Z, Cox AJ, van Eeden P, Allen TJ et al. Endothelin receptor antagonism ameliorates mast cell infiltration, vascular hypertrophy, and epidermal growth factor expression in experimental diabetes. Circ Res 2000;86:158-65.
31. Mayhan WG. Leukocyte adherence contributes to disruption of the blood-brain barrier during activation of mast cells. Brain Res 2000;869;112-20.
32. Saharay M, Shields DA, Porter JB, Scurr JH, Coleridge-Smith PD. Leukocyte activity in the microcirculation of the leg in patients with chronic venous disease. J Vasc Surg 1997;26:265-73.
33. O'Neill JF. The effects on venous endothelium of alterations in blood flow through the vessels in vein walls and the possible relation to thrombosis. Ann Surg 1947;126: 270-88.
34. Lefebvre D, Lescalie F. Vascularization of the wall of the superficial veins. Anatomic study of the vasa vasorum. J Mal Vasc 1996;21 Suppl C:245-8.
35. Bankl HC, Groschmidt K, Pikula B, Bankl H, Lechner K, Valent P. Mast cells are augmented in deep vein thrombosis and express a profibrinolytic phenotype. Hum Pathol 1999;30:188-94.
36. Seong H. Cho SH, Tam SW, Demissie-Sanders S, Filler SA, Oh CK. Production of plasminogen activator inhibitor-1 by human mast cells and its possible role in asthma. J Immunol 2000;165:3154-61.
37. Michiels C, Arnould T, Thibaut-Vercruyssen R, Bouaziz N, Janssens D, Remacle J. Perfused human saphenous veins for the study of the origin of varicose veins: role of the endothelium and of hypoxia. Int Angiol 1997;16: 134-41.
38. Labropoulos N, Giannoukas AD, Nicolaides AN, Veller M, Leon M, Volteas N. The role of venous reflux and calf muscle pump function in nonthrombotic chronic venous insufficiency. Correlation with severity of signs and symptoms. Arch Surg 1996;131:403-6.
39. Perrot-Applanat M, Cohen-Solal K, Milgrom E, Finet M. Progesterone receptor expression in human saphenous veins. Circulation 1995;92:2975-83.
40. Marsiah A, Berman V, Thole HH, Rose SS, Pasik S, Schwarz H et al. Estrogen and progesterone receptors in normal and varicose veins. Cardiovasc Surg 1999;7:327-31.
41. Reed CE. The importance of eosinophils in the immunology of asthma and allergic disease. Ann Allergy 1994;72: 376-80.
42. Pappas PJ, DeFouw DO, Venezio LM, Gorti R, Padberg FT Jr, Silva MB Jr et al. Morphological assessment of the dermal microcirculation in patients with chronic venous insufficiency. J Vasc Surg 1997;26:784-95.
43. Imamura T, Dubin A, Moore W, Tanaka R, Travis J. Induction of vascular permeability enhancement by human tryptase: dependence on activation of prekallikrein and direct release of bradykinin from kininogens. Lab Invest 1996;74:861-70.
44. Katsamouris AN, Kardoulas DG, Gourtsoyiannis N. The nature of lower extremity venous insufficiency in patients with primary varicose veins. Eur J Vasc Surg 1994;8: 464-71.
45. Gundersen J, Hauge M. Hereditary factors in venous insufficiency. Angiology 1969;20:346-55.
46. Burgess LE, Newhouse BJ, Ibrahim P, Rizzi J, Kashem MA, Hartman A et al. Potent selective nonpeptidic inhibitors of human lung tryptase. Proc Natl Acad Sci U S A 1999;96:8348-52.